Spire Wealth Management »

Gt Biopharma shares owned by Spire Wealth Management

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Spire Wealth Management from 13F filings

Historical chart of Spire Wealth Management investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Spire Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Spire Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $784 994 0.79

More positions owned by Spire Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S P 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Spire Wealth Management

Top funds holding Gt Biopharma

DRW Holdings
SeaCrest Wealth Management
Citadel Advisors
Geode Capital Management
Two Sigma Securities
Parsons Capital Management
Vanguard Group
Wells Fargo & Company
BlackRock
Advisor Group Holdings
Wolff Wiese Magana
Newbridge Financial Services Group
Farther Finance Advisors
UBS Group
Tower Research Capital

View all funds holding Gt Biopharma